Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000821995-12-000046
Filing Date
2012-08-08
Accepted
2012-08-07 17:42:42
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 a2012q210q.htm 10-Q 792855
2 EXHIBIT 31.1 a2012q1ex-3111.htm EX-31.1 9076
3 EXHIBIT 31.2 a2012q1ex-3121.htm EX-31.2 9293
4 EXHIBIT 32.1 a2012q1ex3211.htm EX-32.1 6304
5 EXHIBIT 32.2 a2012q1ex3221.htm EX-32.2 6739
  Complete submission text file 0000821995-12-000046.txt   5018781

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbrx-20120630.xml EX-101.INS 686102
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbrx-20120630.xsd EX-101.SCH 35616
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbrx-20120630_cal.xml EX-101.CAL 62360
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbrx-20120630_def.xml EX-101.DEF 191349
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbrx-20120630_lab.xml EX-101.LAB 436468
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbrx-20120630_pre.xml EX-101.PRE 243124
Mailing Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039
Business Address 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 9739943999
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 121014527
SIC: 2834 Pharmaceutical Preparations